- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The predictive utility of circulating PCSK9 levels on diabetes mellitus ; volume:20 ; number:1 ; day:13 ; month:2 ; year:2021 ; pages:1-3 ; date:12.2021
Cardiovascular diabetology ; 20, Heft 1 (13.2.2021), 1-3, 12.2021
- Creator
-
Peng, Jia
Zhu, Cheng-Gang
Li, Jian-Jun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-021-01226-5
- URN
-
urn:nbn:de:101:1-2021040412112900628550
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Peng, Jia
- Zhu, Cheng-Gang
- Li, Jian-Jun
- SpringerLink (Online service)
Other Objects (12)
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Correction: Circulating levels of PCSK9, ANGPTL3 and lp(a) in stage III breast cancers
Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases
Association between the rs615563 variant of PCSK9 gene and circulating lipids and Type 2 diabetes
Gene Therapy Targeting PCSK9
Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients
Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats
Synthesis of a PCSK9 Inhibitor
Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus
PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Correction: Circulating levels of PCSK9, ANGPTL3 and lp(a) in stage III breast cancers
Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases
Association between the rs615563 variant of PCSK9 gene and circulating lipids and Type 2 diabetes
Gene Therapy Targeting PCSK9
Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients
Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats
Synthesis of a PCSK9 Inhibitor
Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus
PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Sex Differences Associated With Circulating PCSK9 in Patients Presenting With Acute Myocardial Infarction
Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers
Correction: Circulating levels of PCSK9, ANGPTL3 and lp(a) in stage III breast cancers
Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases
Association between the rs615563 variant of PCSK9 gene and circulating lipids and Type 2 diabetes
Gene Therapy Targeting PCSK9
Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients
Enhanced circulating PCSK9 concentration by berberine through SREBP-2 pathway in high fat diet-fed rats
Synthesis of a PCSK9 Inhibitor
Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus